Prior to his appointment as CEO in May 2011, Peter was Finance Director at Keele and Recipharm Ltd, Ashton. Peter was also Finance Director of Cobra Biomanufacturing Plc up to its acquisition by Recipharm in 2010, and he has been at the Keele facility for over 8 years. Prior to Cobra he was employed in a variety of senior financial and corporate development roles. Peter qualified as a Chartered Management Accountant in 1996 and in 2001 was awarded an MBA with distinction jointly from the Manchester Business School and the University of Wales.